Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Division of Anatomic Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Stem Cells Transl Med. 2017 Apr;6(4):1168-1177. doi: 10.1002/sctm.16-0316. Epub 2017 Feb 24.
Recruitment of neutrophils and monocytes/macrophages to the site of vascular injury is mediated by binding of chemoattractants to interleukin (IL) 8 receptors RA and RB (IL8RA/B) C-C chemokine receptors (CCR) 2 and 5 expressed on neutrophil and monocyte/macrophage membranes. Endothelial cells (ECs) derived from rat-induced pluripotent stem cells (RiPS) were transduced with adenovirus containing cDNA of IL8RA/B and/or CCR2/5. We hypothesized that RiPS-ECs overexpressing IL8RA/B (RiPS-IL8RA/B-ECs), CCR2/5 (RiPS-CCR2/5-ECs), or both receptors (RiPS-IL8RA/B+CCR2/5-ECs) will inhibit inflammatory responses and neointima formation in balloon-injured rat carotid artery. Twelve-week-old male Sprague-Dawley rats underwent balloon injury of the right carotid artery and intravenous infusion of (a) saline vehicle, (b) control RiPS-Null-ECs (ECs transduced with empty virus), (c) RiPS-IL8RA/B-ECs, (d) RiPS-CCR2/5-ECs, or (e) RiPS-IL8RA/B+CCR2/5-ECs. Inflammatory mediator expression and leukocyte infiltration were measured in injured and uninjured arteries at 24 hours postinjury by enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry, respectively. Neointima formation was assessed at 14 days postinjury. RiPS-ECs expressing the IL8RA/B or CCR2/5 homing device targeted the injured arteries and decreased injury-induced inflammatory cytokine expression, neutrophil/macrophage infiltration, and neointima formation. Transfused RiPS-ECs overexpressing IL8RA/B and/or CCR2/5 prevented inflammatory responses and neointima formation after vascular injury. Targeted delivery of iPS-ECs with a homing device to inflammatory mediators in injured arteries provides a novel strategy for the treatment of cardiovascular diseases. Stem Cells Translational Medicine 2017;6:1168-1177.
招募中性粒细胞和单核细胞/巨噬细胞到血管损伤部位是由趋化因子与白细胞介素(IL)8 受体 RA 和 RB(IL8RA/B)C-C 趋化因子受体(CCR)2 和 5 结合介导的,这些受体表达在中性粒细胞和单核细胞/巨噬细胞膜上。用含有 IL8RA/B 和/或 CCR2/5 cDNA 的腺病毒转导大鼠诱导多能干细胞(RiPS)衍生的内皮细胞(ECs)。我们假设过表达 IL8RA/B(RiPS-IL8RA/B-ECs)、CCR2/5(RiPS-CCR2/5-ECs)或两种受体(RiPS-IL8RA/B+CCR2/5-ECs)的 RiPS-ECs 将抑制球囊损伤大鼠颈动脉中的炎症反应和新生内膜形成。12 周龄雄性 Sprague-Dawley 大鼠接受右侧颈动脉球囊损伤,并静脉输注(a)生理盐水载体、(b)对照 RiPS-Null-ECs(转导空病毒的 ECs)、(c)RiPS-IL8RA/B-ECs、(d)RiPS-CCR2/5-ECs 或(e)RiPS-IL8RA/B+CCR2/5-ECs。通过酶联免疫吸附试验(ELISA)和免疫组织化学分别在损伤和未损伤动脉中测量损伤后 24 小时的炎症介质表达和白细胞浸润。在损伤后 14 天评估新生内膜形成。表达 IL8RA/B 或 CCR2/5 归巢装置的 RiPS-EC 靶向损伤动脉,并降低损伤诱导的炎症细胞因子表达、中性粒细胞/巨噬细胞浸润和新生内膜形成。输注过表达 IL8RA/B 和/或 CCR2/5 的 RiPS-EC 可预防血管损伤后的炎症反应和新生内膜形成。将带有归巢装置的 iPS-EC 靶向输送到损伤动脉中的炎症介质为心血管疾病的治疗提供了一种新策略。《干细胞转化医学》2017;6:1168-1177。